主动脉瓣的全球市场:现状分析与预测(2021年～2027年)

全球主动脉瓣的市场规模在预测期间(2021年～2027年)中预计将以约13％的年复合成长率成长。

心臟瓣膜症的盛行率的上升和老年人口的增加，成为促进主动脉瓣市场成长的要素之一。再加上日益严重的全球瓣膜病也在推动市场增长。

本报告提供全球主动脉瓣市场的相关调查，提供市场洞察，市场趋势，竞争模式，企业概要等全面性资讯。

目录

第1章 市场简介

• 市场定义
• 限制
• 相关利益者
• 报告所使用的货币

第2章 调查方法或假设

• 主动脉瓣市场调查流程
• 主动脉瓣市场调查手法
• 预测方法
• 受访者简介
• 主动脉瓣市场调查的主要目的

第3章 市场摘要

第4章 摘要整理

第5章 主动脉瓣市场上COVID-19影响

第6章 主动脉瓣市场收益(2019年～2027年)

第7章 市场洞察:各瓣类型

• 组织/生物的
• 机械性

第8章 市场洞察:各缝合线类型

• 缝合
• 无缝合

第9章 市场洞察:各手术

• 剖腹手术
• 微创手术

第10章 市场洞察:各终端用户

• 医院
• 门诊病人手术中心

第11章 市场洞察:各地区

• 北美
  • 美国
  • 加拿大
  • 其他的北美
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他的欧洲
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 其他的亚太地区
• 其他

第12章 主动脉瓣市场动态

• 推动市场要素
• 市场课题
• 影响分析

第13章 主动脉瓣市场机会

第14章 主动脉瓣市场趋势

第15章 相关法规

第16章 需求与供给面分析

• 需求面分析
• 供给面分析
  • 主要产品的销售
  • 主要企业的伙伴关係
  • 主要企业的扩大
  • 主要的合併和收购

第17章 价值链分析

第18章 竞争模式

• 波特的五力分析
  • 供应商谈判力
  • 买主谈判力
  • 产业的竞争
  • 替代品的可得性
  • 新加入厂商业者的威胁

第19章 公司概要

• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• CryoLife Inc.
• Medtronic plc
• LivaNova PLC
• Abbott Laboratories
• JenaValve Technology Inc.
• Thubrikar Aortic Valve Inc.
• LifeNet Health Inc.
• Coroneo Inc.

第20章 免责声明

Global Aortic valve Market is anticipated to grow with an elevated CAGR of around 13% over the forecast period (2021-2027). The aortic valve allows blood to flow in the right direction in the heart. It separates the main pump chamber of the heart (left ventricle) from the main arteries that supply the body with oxygen-rich blood (aorta). Each time the ventricle contracts, the aortic valve opens, allowing blood to flow from the left ventricle to the aorta. When the ventricles relax, the aortic valve closes and prevents blood from flowing back into the ventricles.

The growing prevalence of heart valve disease coupled with the rising geriatric population is another factor contributing to the growth of the aortic valve market. For instance, according to the United Nations, In 2019, 13.2% of the worldwide population was aged 60 years or above. Further, it is anticipated that nearly 21.4% of the total worldwide population will be aged 60 years or over by 2050. In view of these facts, there is a rising prevalence of aortic regurgitation which creates the need for heart valve replacement which in turn is driving the aortic valve market globally.

Furthermore, The rising worldwide demand for the aortic valve is because of the increase in valvular diseases globally. For instance, as per CDC, About 2.5% of the U.S. population has valvular heart disease, but it is more common in older adults. About 13% of people born before 1943 have valvular heart disease. However, some of the restraints in the market include stringent regulatory framework and product failure and recalls are impeding the growth of this market all over the world. Boston Scientific Corporation, Edwards Lifesciences Corporation, CryoLife Inc., Medtronic plc, LivaNova PLC, Abbott Laboratories, JenaValve Technology Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Coroneo Inc, are some of the prominent players operating in the aortic valve market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with aortic valves.

Insights Presented in the Report

"Amongst Valve Type, Tissue/Biological segment holds the major share"

Based on valve type, the market is bifurcated into tissue/biological type and mechanical type. The tissue/biological type segment occupied the major share of the artificial blood vessels market in 2020 and it is expected to grow with a substan]ial CAGR in the upcoming years owing to the various advantages associated with this type of valve such as avoiding lifelong warfarin therapy to prevent the formation of blood clots, long-term durability, and free from reoperation for valve degeneration. Owing to this, many key industry players are launching new and advanced products in the market. For example, in September 2021, Abbott announced that the FDA has approved the company's Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease.

"Amongst Suture Type, Sutureless segment holds the major share"

Based on suture type, the aortic valve market is bifurcated into sutured and sutureless. The sutureless segment occupied the major share of the aortic valve market in 2020 and it is expected to grow with a substantial CAGR in the upcoming years owing to its reduced duration of cross-clamp and cardiopulmonary bypass (CPB) procedures compared to sutured valves.

"Amongst Procedure, Minimally Invasive Surgery segment holds the major share"

Based on the procedure, the market is bifurcated into open surgery and minimally invasive surgery. The minimally invasive surgery segment occupied the major share of the aortic valve market in 2020 and it is expected to grow with a substantial CAGR in the upcoming years as minimally invasive surgery causes less trauma to the patients and facilitates faster recovery than open-heart surgery as the geriatric population takes more time to get recover from surgery.

"Amongst End-Users, hospitals segment holds the major share"

Based on end-users, the market is fragmented into hospitals, and ambulatory surgical centers. In 2020, hospitals segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the increasing construction of hospitals and a surge in the number of heart surgeries in the hospital setting. However, ambulatory surgical centers are also likely to witness the fastest growth during the forecast period.

"Europe represents one of the largest markets of aortic valve market"

For a better understanding of the market dynamics of the aortic valve market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. Europe constitutes a major market for the aortic valve market industry and generated revenue of USD XX Million in 2020 owing to strong healthcare infrastructure and growing adoption of the aortic valve in the region.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts

• The report presents a quick review of overall industry performance at one glance

• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

• The study comprehensively covers the market across different segments

• Deep dive regional level analysis of the industry

Customization Options:

The global aortic valve market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Limitation
• 1.3. Stakeholders
• 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Aortic Valve Market
• 2.2. Research Methodology of the Aortic Valve Market
• 2.3. Forecasting Method
• 2.4. Respondent Profile
• 2.5. Main Objective of the Aortic Valve Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 AORTIC VALVE MARKET COVID-19 IMPACT

6 AORTIC VALVE MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY VALVE TYPE

• 7.1. Tissue/ Biological
• 7.2. Mechanical

8 MARKET INSIGHTS BY SUTURE TYPE

• 8.1. Sutured
• 8.2. Sutureless

9 MARKET INSIGHTS BY PROCEDURE

• 9.1. Open Surgery
• 9.2. Minimally Invasive Surgery

10 MARKET INSIGHTS BY END-USERS

• 10.1 Hospitals
• 10.2 Ambulatory Surgery Centers

11 MARKET INSIGHTS BY REGION

• 11.1. North America
  • 11.1.1 US
  • 11.1.2 Canada
  • 11.1.3 Rest of North America
• 11.2 Europe
  • 11.2.1 Germany
  • 11.2.2 UK
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Rest of Europe
• 11.3 Asia-Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 Australia
  • 11.3.5 Rest of Asia-Pacific
• 11.4 Rest of World

12 AORTIC VALVE MARKET DYNAMICS

• 12.1 Market Drivers
• 12.2 Market Challenges
• 12.3 Impact Analysis

13 AORTIC VALVE MARKET OPPORTUNITIES

14 AORTIC VALVE MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

• 16.1 Demand Side Analysis
• 16.2 Supply Side Analysis
  • 16.2.1 Top Product Launches
  • 16.2.2 Top Business Partnerships
  • 16.2.3 Top Business Expansions
  • 16.2.4 Top Merger and Acquisitions

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

• 18.1 Porter's Five forces analysis
  • 18.1.1 Bargaining power of Supplier
  • 18.1.2 Bargaining power of Buyer
  • 18.1.3 Industry Rivalry
  • 18.1.4 Availability of Substitute
  • 18.1.5 Threat of new Entrants

19 COMPANY PROFILED

• 19.1 Boston Scientific Corporation
• 19.2 Edwards Lifesciences Corporation
• 19.3 CryoLife Inc.
• 19.4 Medtronic plc
• 19.5 LivaNova PLC
• 19.6 Abbott Laboratories
• 19.7 JenaValve Technology Inc.
• 19.8 Thubrikar Aortic Valve Inc.
• 19.9 LifeNet Health Inc.
• 19.1 Coroneo Inc.

20 DISCLAIMER